Haiti: coffee and mango production in a changing climate

Coffee and mango contribute significantly to Haiti’s agricultural gross domestic product and export revenues. Generating income valued at US$11 million in 2011, mango has become one of the country’s most important export commodities. In contrast, coffee exports steadily declined from$7 million to $1 million between 2000 and 2010, even though demand for high-quality Haitian coffee has actually increased on the global market. A recent study conducted by the International Center for Tropical Agriculture (CIAT) and Catholic Relief Services (CRS) revealed that future changes in temperature and rainfall patterns will have significant effects on the suitability of coffee and mango for production in Haiti. While mango will continue to be highly viable, coffee will become considerably less suitable for production at lower elevations. Changing climatic conditions could also lower quality and yields in current coffee-producing regions, such as Plaisance and Dondon in the North and Beaumont in the Southwest. To cope with the challenges that coffee and mango growers are likely to face, it will be important to promote the diversification of agricultural systems, introduce improved coffee varieties, offer financial incentives to adopt sustainable land use practices, build capacity among smallholders, and foster the sharing of expertise

The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: Celebrating the legacy of Paul Lacy

Over the past three decades the pancreatic islet of Langerhans has taken center stage as an endocrine microorgan whose glucoregulatory function is highly explicable on the basis of the increasingly well understood activities of three highly interactive secretory cells. Islet dysfunction underlies both type 1 and type 2 diabetes mellitus (DM); its protection from immune attack and gluco-and lipo-toxicity may prevent the development of DM; and its replacement by non-surgical transplantation may be curative of DM. During a career marked by vision, focus and tenacity, Paul Lacy contributed substantially to the development of each of these concepts. In this review we focus on Lacy's contribution to the development of the concept of the islet as a micro-organ, how this foreshadowed our current detailed understanding of single cell function and cell-cell interactions and how this led to a reduced model of islet function encouraging islet transplantation. Next, we examine how clinical allotransplantation, first undertaken by Lacy, has contributed to a more complex view of the interaction of islet endocrine cells with its circulation and neighboring tissues, both “in situ” and after transplantation. Lastly, we consider recent developments in some alternative approaches to treatment of DM that Lacy could glimpse on the horizon but did not have the chance to participate in